| Ankylosing spondylitis

Bimzelx vs Purified Cortrophin Gel

Side-by-side clinical, coverage, and cost comparison for ankylosing spondylitis.

Deep comparison between: Bimzelx vs Purified Cortrophin Gel with Prescriber.AI

AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.

Safety signalsPurified Cortrophin Gel has a higher rate of injection site reactions vs Bimzelx based on FDA-approved prescribing information

Coverage gaps3 major payers require step therapy for Purified Cortrophin Gel but not Bimzelx, including UnitedHealthcare

Category

Bimzelx

Purified Cortrophin Gel

At A Glance

RouteSC injection

FrequencyEvery 4-8 weeks

ClassIL-17A and F antagonist

RouteSC/IM injection

ClassCorticotropin (ACTH)

Indications

Psoriasis vulgaris
Arthritis, Psoriatic
Non-Radiographic Axial Spondyloarthritis
Ankylosing spondylitis
Hidradenitis Suppurativa

Arthritis, Psoriatic
Rheumatoid Arthritis
Ankylosing spondylitis
Primary gout
Lupus Erythematosus, Systemic
Polymyositis
Stevens-Johnson Syndrome
Psoriasis
Dermatitis, Atopic
Serum Sickness
Allergic Conjunctivitis
Keratitis
Iritis
Iridocyclitis
Uveitis
Optic Neuritis
Chorioretinitis
Sarcoidosis
Nephrotic Syndrome
Multiple Sclerosis

Dosing

Psoriasis vulgaris 320 mg SC at Weeks 0, 4, 8, 12, and 16, then every 8 weeks thereafter; for patients weighing 120 kg or more, consider 320 mg every 4 weeks after Week 16.

Arthritis, Psoriatic, Non-Radiographic Axial Spondyloarthritis, Ankylosing spondylitis 160 mg SC every 4 weeks; for Arthritis, Psoriatic with coexistent moderate to severe plaque psoriasis, use the plaque psoriasis dosing regimen.

Hidradenitis Suppurativa 320 mg SC at Weeks 0, 2, 4, 6, 8, 10, 12, 14, and 16, then every 4 weeks thereafter.

Arthritis, Psoriatic, Rheumatoid Arthritis, Ankylosing spondylitis, Primary gout, Lupus Erythematosus, Systemic, Polymyositis, Stevens-Johnson Syndrome, Psoriasis, Dermatitis, Atopic, Serum Sickness, Allergic Conjunctivitis, Keratitis, Iritis, Iridocyclitis, Uveitis, Optic Neuritis, Chorioretinitis, Sarcoidosis, Nephrotic Syndrome Dose individualized based on disease severity, plasma and urine corticosteroid levels, and patient response; administer SC or IM; verify adrenal responsiveness prior to treatment (up to 80 units as a single injection); chronic doses above 40 units daily associated with uncontrollable adverse effects.

Multiple Sclerosis 80-120 units daily SC or IM for 2-3 weeks for acute exacerbations.

Contraindications

—

Intravenous administration
Scleroderma
Osteoporosis
Systemic fungal infections
Ocular herpes simplex
Recent surgery
History of or presence of a peptic ulcer
Congestive heart failure
Hypertension
Sensitivity to proteins derived from porcine sources
Primary adrenocortical insufficiency
Adrenocortical hyperfunction

Drug Interactions

833View drug interactions

648View drug interactions

Adverse Reactions

Most common (>=1%) Upper respiratory infections, oral candidiasis, headache, injection site reactions, tinea infections, gastroenteritis, herpes simplex infections, acne, folliculitis, fatigue, diarrhea, urinary tract infection

Serious Suicidal ideation and behavior, serious infections, liver biochemical abnormalities, inflammatory bowel disease

Postmarketing Conjunctivitis, esophageal candidiasis

Fluid and Electrolyte Sodium retention, hypokalemic alkalosis, fluid retention, calcium loss, potassium loss

Musculoskeletal Muscle weakness, loss of muscle mass, steroid myopathy, osteoporosis, vertebral compression fractures, aseptic necrosis of femoral and humeral heads, pathologic fracture of long bones

Gastrointestinal Peptic ulcer with possible perforation and hemorrhage, abdominal distention, ulcerative esophagitis, pancreatitis

Dermatologic Injection site reactions, impaired wound healing, increased sweating, thin fragile skin, suppression of skin test reactions, petechiae and ecchymoses, acne, hyperpigmentation, facial erythema

Cardiovascular Hypertension, congestive heart failure, necrotizing angiitis

Neurological Convulsions, increased intracranial pressure with papilledema, headache, vertigo

Endocrine Menstrual irregularities, Cushingoid state, suppression of growth in children, secondary adrenocortical and pituitary insufficiency, decreased carbohydrate tolerance, manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic agents, hirsutism

Ophthalmic Posterior subcapsular cataracts, increased intraocular pressure, glaucoma with possible damage to optic nerve, exophthalmos

Metabolic Negative nitrogen balance due to protein catabolism

Allergic Dizziness, nausea and vomiting, skin reactions, anaphylaxis (anaphylactic shock, urticaria, respiratory compromise, edema)

Miscellaneous Weight gain, abscess, development of antibodies and loss of stimulatory effect

Pharmacology

Bimekizumab-bkzx is a humanized IgG1 monoclonal antibody that selectively binds IL-17A, IL-17F, and IL-17AF cytokines, inhibiting their interaction with the IL-17 receptor complex and suppressing the release of proinflammatory cytokines and chemokines.

Purified Cortrophin Gel is an anterior pituitary hormone (corticotropin/ACTH) that stimulates the functioning adrenal cortex to produce and secrete adrenocortical hormones; it is formulated as a porcine-derived purified ACTH in a sterile gelatin solution for prolonged activity.

View Full FDA Information

View full FDA information

Enter your patient's insuranceCheck specific coverage details for your patient.

Most Common Insurance

Anthem BCBS

Bimzelx